Correlation of contrast-enhanced ultrasound with two distinct types of blood vessels for the assessment of angiogenesis in lewis lung carcinoma

Ultraschall in der Medizin

Volumn 35, Issue 5, 2014, Pages 468-472

  Zhuo, J ^a   Fu, W ^a   Liu, S ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

radiobiology; tumor; ultrasound

Indexed keywords

EID: 84889779386     PISSN: 01724614     EISSN: 14388782     Source Type: Journal    
DOI: 10.1055/s-0033-1356194     Document Type: Article

References (26)

1. Brown L. F., Berse B., Jackman R. W. et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol: 1995; 26 86 91
2. Wang Z., Tang J., An L. et al. Contrast-enhanced ultrasonography for assessment of tumor vascularity in hepatocellular carcinoma. J Ultrasound Med: 2007; 26 757 762
3. Wang B., Gao Z. Q., Yan X. Correlative study of angiogenesis and dynamic contrast-enhanced magnetic resonance imaging features of hepatocellular carcinoma. Acta Radiol: 2005; 46 353 358
4. Li W. W. Tumor angiogenesis: molecular pathology, therapeutic targeting, and imaging. Acad Radiol: 2000; 7 800 811
5. Meyerowitz C. B., Fleischer A. C., Pickens D. R. et al. Quantification of tumor vascularity and flow with amplitude color Doppler sonography in an experimental model: preliminary results. J Ultrasound Med: 1996; 15 827 833
6. Wilson S. R., Burns P. N., Muradali D. et al. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis. Radiology: 2000; 215 153 161
7. Masaki T., Ohkawa S., Amano A. et al. Noninvasive assessment of tumor vascularity by contrast-enhanced ultrasonography and the prognosis of patients with nonresectable pancreatic carcinoma. Cancer: 2005; 103 1026 1035
8. Poblet E., Gonzalez-Palacios F., Jimenez F. J. Different immunoreactivity of endothelial markers in well and poorly differentiated areas of angiosarcomas. Virchows Arch: 1996; 428 217 221
9. Bertram J. S., Janik P. Establishment of a cloned line of Lewis Lung Carcinoma cells adapted to cell culture. Cancer Lett: 1980; 11 63 73
10. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med: 1995; 1 27 31
11. Kiessling F., Krix M., Heilmann M. et al. Comparing dynamic parameters of tumor vascularization in nude mice revealed by magnetic resonance imaging and contrast-enhanced intermittent power Doppler sonography. Invest Radiol: 2003; 38 516 524
12. Carmeliet P., Jain R. K. Angiogenesis in cancer and other diseases. Nature: 2000; 407 249 257
13. Kerbel R. S. Tumor angiogenesis: past, present and the near future. Carcinogenesis: 2000; 21 505 515
14. Fox S. B., Gasparini G., Harris A. L. Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs. Lancet Oncol: 2001; 2 278 289
15. Fleischer A. C. Sonographic depiction of tumor vascularity and flow: from in vivo models to clinical applications. J Ultrasound Med: 2000; 19 55 61
16. Goertz D. E., Yu J. L., Kerbel R. S. et al. High-frequency Doppler ultrasound monitors the effects of antivascular therapy on tumor blood flow. Cancer Res: 2002; 62 6371 6375
17. Gee M. S., Saunders H. M., Lee J. C. et al. Doppler ultrasound imaging detects changes in tumor perfusion during antivascular therapy associated with vascular anatomic alterations. Cancer Res: 2001; 61 2974 2982
18. Ko E. Y., Lee S. H., Kim H. H. et al. Evaluation of tumor angiogenesis with a second-generation US contrast medium in a rat breast tumor model. Korean J Radiol: 2008; 9 243 249
19. Kim E. A., Yoon K. H., Lee Y. H. et al. Focal hepatic lesions: contrast-enhancement patterns at pulse-inversion harmonic US using a microbubble contrast agent. Korean J Radiol: 2003; 4 224 233
20. Schneider M., Arditi M., Barrau M. B. et al. BR1: a new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles. Invest Radiol: 1995; 30 451 457
21. Weidner N., Folkman J., Pozza F. et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst: 1992; 84 1875 1887
22. Bosari S., Lee A. K., DeLellis R. A. et al. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol: 1992; 23 755 761
23. Toi M., Bando H., Kuroi K. The predictive value of angiogenesis for adjuvant therapy in breast cancer. Breast Cancer: 2000; 7 311 314
24. Anastassiou G., Duensing S., Steinhoff G. et al. Platelet endothelial cell adhesion molecule-1 (PECAM-1): a potential prognostic marker involved in leukocyte infiltration of renal cell carcinoma. Oncology: 1996; 53 127 132
25. Imao T., Egawa M., Takashima H. et al. Inverse correlation of microvessel density with metastasis and prognosis in renal cell carcinoma. Int J Urol: 2004; 11 948 953
26. Marshall F. F. Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinoma. J Urol: 2003; 170 694.